Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glioblastomas (GBM)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT03225300
What this trial is testing

Simultaneous Integrated Boost in Malignant Glioma Patients Treated With Chemoradiation

Who this might be right for
Glioblastoma MultiformeChemoradiation
Taichung Veterans General Hospital 120
Early research (Phase 1)Study completedNCT01480050
What this trial is testing

Mibefradil Dihydrochloride and Temozolomide in Treating Patients With Recurrent Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 28
Large-scale testing (Phase 3)UnknownNCT01656980
What this trial is testing

Safety and Efficacy Study of Intracranially Implanted Carmustine to Treat Newly Diagnosed Malignant Glioma

Who this might be right for
Anaplastic AstrocytomaAnaplastic OligodendrogliomaAnaplastic Oligoastrocytoma+1 more
Shandong Lanjin Pharmaceuticals Co.,Ltd 236
Testing effectiveness (Phase 2)Temporarily pausedNCT07708961
What this trial is testing

Temozolomide, With or Without WSD0922-FU, for the Treatment of EGFR-Mutant, IDH-Wildtype Glioblastoma

Who this might be right for
Glioblastoma, IDH-Wildtype
Mayo Clinic 60
Testing effectiveness (Phase 2)Looking for participantsNCT06814496
What this trial is testing

Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors

Who this might be right for
MelanomaMedullary Thyroid CancerSinonasal Undifferentiated Carcinoma+8 more
University of Arizona 30
Testing effectiveness (Phase 2)Study completedNCT03732352
What this trial is testing

18F-FDG PET and Osimertinib in Evaluating Glucose Utilization in Patients with EGFR Activated Recurrent Glioblastoma

Who this might be right for
EGFR Gene AmplificationEGFR Gene MutationGlioblastoma+3 more
Jonsson Comprehensive Cancer Center 12
Not applicableLooking for participantsNCT05775458
What this trial is testing

Glutamate Excitotoxicity and Its Role in Glioblastoma Biology

Who this might be right for
Brain Tumor, Primary
IRCCS San Raffaele 50
Not applicableUnknownNCT02152748
What this trial is testing

Disease Progression and Treatment-induced Alterations in Glioblastoma

Who this might be right for
Brain Tumor
Medical University of Vienna 60
Not applicableEnded earlyNCT02905643
What this trial is testing

Discerning Pseudoprogression vs True Tumor Growth in GBMs

Who this might be right for
Glioblastoma
Ascension Health 1
Not applicableUnknownNCT02520635
What this trial is testing

Supra-early Post-Surgery Chemotherapy in the Treatment on GBM Patients

Who this might be right for
Glioblastoma
Beijing Tiantan Hospital 180
Early research (Phase 1)Looking for participantsNCT06641908
What this trial is testing

Anti-GD2 ADC M3554 in Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
EMD Serono Research & Development Institute, Inc. 65
Not applicableNot Yet RecruitingNCT06617208
What this trial is testing

Prognostic IntraOperative Biomarkers ideNtification in Tumor rElatEd suRgery

Who this might be right for
GliomaGlioblastoma (GBM)Brain Tumor-Glioma
Erasmus Medical Center 10
Testing effectiveness (Phase 2)Ended earlyNCT01884740
What this trial is testing

Intraarterial Infusion Of Erbitux and Bevacizumab For Relapsed/Refractory Intracranial Glioma In Patients Under 22

Who this might be right for
Glioblastoma MultiformeFibrillary Astrocytoma of BrainGlioma of Brainstem+5 more
Weill Medical College of Cornell University 13
Not applicableUnknownNCT05328089
What this trial is testing

Vacuolar ATPase and Drug Resistance of High Grade Gliomas

Who this might be right for
Glioblastoma Multiforme
University of Milano Bicocca 20
Testing effectiveness (Phase 2)Study completedNCT00209989
What this trial is testing

Phase II Trial to Assess the Radiosensitizing Effect of ZARNESTRA in Patients With Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme
Institut Claudius Regaud 27
Not applicableStudy completedNCT03770468
What this trial is testing

Molecular Genetic, Host-derived and Clinical Determinants of Long-term Survival in Glioblastoma

Who this might be right for
Glioblastoma
European Organisation for Research and Treatment of Cancer - EORTC 599
Early research (Phase 1)Study completedNCT01547546
What this trial is testing

GDC-0084 in Patients With Progressive or Recurrent High-Grade Glioma

Who this might be right for
Glioblastoma, Glioma
Genentech, Inc. 29
Testing effectiveness (Phase 2)Looking for participantsNCT06687681
What this trial is testing

Injection of Active Allogeneic Natural Killer Cells in Patients With Gliomas

Who this might be right for
Glioma Glioblastoma MultiformeHigh Grade Glioma (III or IV)
Marzieh Ebrahimi 40
Early research (Phase 1)Study completedNCT03234712
What this trial is testing

A Study Evaluating the Safety, Pharmacokinetics, and Anti-tumor Activity of ABBV-321 in Subjects With Advanced Solid Tumors Associated With Overexpression of the Epidermal Growth Factor Receptor (EGFR)

Who this might be right for
Advanced Solid Tumors Cancer
AbbVie 62
Not applicableNot Yet RecruitingNCT06764537
What this trial is testing

Evaluation of in Vitro Antitumor Activity of GD2 CAR-T Cells in Glioblastoma

Who this might be right for
Glioblastoma
Central Hospital, Nancy, France 18
Next Page